Abstract of original contributions to be presented at the American College of Cardiology 52nd Annual Scientific Session, March 30–April 2, 2003, Chicago, Illinois Cardiac function and heart failure
Do patients necessarily have to start with an angiotension converting enzyme inhibitor in the treatment of heart failure? Results of the CARMEN (Carvedilol ACE Inhibitor Remodeling Mild CHF Evaluation) study